To achieve this goal, we studied the effect of in vivo shRNA-mediated GPAT gene silencing on bioactive lipid accumulation and the insulin signaling pathway in the gastrocnemius muscle of mice with diet-induced insulin resistance. The gene discussed is INS; the disease is Insulin resistance.